Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rita Fuerst

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chembiochem : a European Journal of Chemical Biology|September 4, 2020
Activity-Based Protein Profiling (ABPP) of OxidoreductasesRita Fuerst, Rolf Breinbauer
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2017
Virtual High-Throughput Screening for Matrix Metalloproteinase InhibitorsJun Yong Choi, Rita Fuerst
Bioorganic & Medicinal Chemistry|September 26, 2018
Development of matrix metalloproteinase-13 inhibitors - A structure-activity/structure-property relationship studyRita Fuerst, Jun Yong Choi, Anna M Knapinska, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2022
Development of a putative Zn<sup>2+</sup>-chelating but highly selective MMP-13 inhibitorRita Fuerst, Jun Yong Choi, Anna M Knapinska, et al.
Journal of Medicinal Chemistry|June 28, 2017
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 InhibitorsJun Yong Choi, Rita Fuerst, Anna M Knapinska, et al.
Bioorganic & Medicinal Chemistry|August 12, 2019
Synthesis and biological evaluation of cis-restrained carbocyclic combretastatin A-4 analogs: Influence of the ring size and saturation on cytotoxic propertiesChristina Nowikow, Rita Fuerst, Maria Kauderer, et al.
Journal of Medicinal Chemistry|April 11, 2017
Second Generation Triple-Helical Peptide Inhibitors of Matrix MetalloproteinasesManishabrata Bhowmick, Dorota Tokmina-Roszyk, Lillian Onwuha-Ekpete, et al.
Cancer Research|February 2, 2021
Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall SurvivalChen Hao Lo, Gemma Shay, Jeremy J McGuire, et al.
Cell Chemical Biology|December 4, 2018
The Hairpin Form of r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup> in c9ALS/FTD Is Repeat-Associated Non-ATG Translated and a Target for Bioactive Small MoleculesZi-Fu Wang, Andrei Ursu, Jessica L Childs-Disney, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2022
A blood-brain penetrant RNA-targeted small molecule triggers elimination of r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup> in c9ALS/FTD via the nuclear RNA exosomeJessica A Bush, Samantha M Meyer, Rita Fuerst, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|September 4, 2020
Activity-Based Protein Profiling (ABPP) of OxidoreductasesRita Fuerst, Rolf Breinbauer
Methods in Molecular Biology (Clifton, N.J.)|March 17, 2017
Virtual High-Throughput Screening for Matrix Metalloproteinase InhibitorsJun Yong Choi, Rita Fuerst
Bioorganic & Medicinal Chemistry|September 26, 2018
Development of matrix metalloproteinase-13 inhibitors - A structure-activity/structure-property relationship studyRita Fuerst, Jun Yong Choi, Anna M Knapinska, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2022
Development of a putative Zn<sup>2+</sup>-chelating but highly selective MMP-13 inhibitorRita Fuerst, Jun Yong Choi, Anna M Knapinska, et al.
Journal of Medicinal Chemistry|June 28, 2017
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 InhibitorsJun Yong Choi, Rita Fuerst, Anna M Knapinska, et al.
Bioorganic & Medicinal Chemistry|August 12, 2019
Synthesis and biological evaluation of cis-restrained carbocyclic combretastatin A-4 analogs: Influence of the ring size and saturation on cytotoxic propertiesChristina Nowikow, Rita Fuerst, Maria Kauderer, et al.
Journal of Medicinal Chemistry|April 11, 2017
Second Generation Triple-Helical Peptide Inhibitors of Matrix MetalloproteinasesManishabrata Bhowmick, Dorota Tokmina-Roszyk, Lillian Onwuha-Ekpete, et al.
Cancer Research|February 2, 2021
Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall SurvivalChen Hao Lo, Gemma Shay, Jeremy J McGuire, et al.
Cell Chemical Biology|December 4, 2018
The Hairpin Form of r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup> in c9ALS/FTD Is Repeat-Associated Non-ATG Translated and a Target for Bioactive Small MoleculesZi-Fu Wang, Andrei Ursu, Jessica L Childs-Disney, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2022
A blood-brain penetrant RNA-targeted small molecule triggers elimination of r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup> in c9ALS/FTD via the nuclear RNA exosomeJessica A Bush, Samantha M Meyer, Rita Fuerst, et al.
Pageof 2